5311 - 5320 of 8808 Results
Title
Year
-
OPENTitle: The effect of cardiovascular risk on disease progression in de novo Parkinson's disease patients: An observational analysisJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2023.1138546Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2023.1138546/pdfCitation Count: 0
-
OPENTitle: Editorial: Brain stimulation in cognition and diseaseJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 17Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2023.1213272Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2023.1213272/pdfCitation Count: 0
-
OPENTitle: Motor Response With Apomorphine Sublingual Film and Levodopa in Patients With OFF EpisodesJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol: 13Issue #: 2Start Page: 75End Page: 84Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.2217/nmt-2022-0038Best OA location URL: https://doi.org/10.2217/nmt-2022-0038Citation Count: 5
-
OPENTitle: Measuring Up: A Comparison of TapeStation 4200 and Bioanalyzer 2100 as Measurement Tools for RNA Quality in Postmortem Human Brain SamplesJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 24Issue #: 18Start Page: 13795End Page: 13795Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms241813795Best OA location URL: https://www.mdpi.com/1422-0067/24/18/13795/pdf?version=1694073777Citation Count: 10
-
OPENTitle: A novel synthetic activator of Nurr1 induces dopaminergic gene expression and protects against 6-hydroxydopamine neurotoxicity in vitroJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 607Issue #:Start Page: 83End Page: 89Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2015.09.015Citation Count: 45
-
OPENTitle: Acquired dysregulation of dopamine homeostasis reproduces features of Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-020-00134-xBest OA location URL: https://www.nature.com/articles/s41531-020-00134-x.pdfCitation Count: 44
- Dopamine Buffering Capacity Imaging: A Pharmacodynamic fMRI Method for Staging Parkinson Disease2020OPENTitle: Dopamine Buffering Capacity Imaging: A Pharmacodynamic fMRI Method for Staging Parkinson DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.00370Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00370/pdfCitation Count: 11
-
RESTRICTEDTitle: Detection of oligomeric forms of α‐synuclein protein in human plasma as a potential biomarker for Parkinson's diseaseJournal Name: The FASEB JournalPublisher: WileyVol: 20Issue #: 3Start Page: 419End Page: 425Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fj.03-1449comCitation Count: 692
- Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau2021OPENTitle: Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tauJournal Name: EMBO Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 13Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/emmm.202114022Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/emmm.202114022Citation Count: 171
- Cannabinoid, CB1 agonists in cervical dystonia: Failure in a phase IIa randomized controlled trial2011RESTRICTEDTitle: Cannabinoid, CB1 agonists in cervical dystonia: Failure in a phase IIa randomized controlled trialJournal Name: Basal GangliaPublisher: Elsevier BVVol: 1Issue #: 2Start Page: 91End Page: 95Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.baga.2011.04.002Citation Count: 34